{"nct_id":"NCT00407303","title":"Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) in Combination With Bortezomib for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma (MCL)","status":"COMPLETED","status_verified_date":"2016-07","start_date":"2006-10","start_date_type":null,"primary_completion_date":"2009-03","primary_completion_date_type":"ACTUAL","completion_date":"2009-11","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["TEVA"]}